Register by Friday, October 17th and Save!
|
Participating Companies:
- Abbott
- Alkermes
- BioVerdant
- BMS
- Codexis
- DSM
- Eisai Research Institute
- Johnson & Johnson PR&D
- Merck
- Novartis
- Pfizer
- Vertex
Sessions Include:
- Challenges in Process Development of API Synthetic Routes
- Tools for Optimization and Scale-up
- Impact of QbD on Process Development
- Impact of Genotoxicity Concerns on Process Development
- Biocatalysis
- Separation at Scale: Chromatography and Crystallization
Pre-Conference Short Course:
Demystifying Process Chemistry
November 17, 2008
8:00am – 12:00pm
Neal Anderson, Ph.D., of Anderson’s Process Solutions, is offering his short course again this year due to popular demand. ‘Demystifying Process Chemistry’ will provide an important update for those working in process research and development of small molecules, and will serve as an advanced introduction for those new to the field. Topics have been selected to presage some of the conference presentations and to further subsequent discussion.
Scientific Advisory Board
Neal G. Anderson, Ph.D., Anderson’s Process Solutions
Robert Hughes, Ph.D., Scientist II, Chemical Development, Vertex Pharmaceuticals, Inc.
Ambarish K. Singh, Ph.D., Associate Director, Chemistry Manufacturing and Control, Bristol-Myers Squibb Co.
Eric Stoner, Ph.D., Associate Research Fellow, GPRD Process Research & Development, Abbott Laboratories
Co-located Event:
Drug Formulation
November 19-20, 2008 | Philadelphia, Pennsylvania
Click here for updated conference information
Discounted Joint Pricing Options Available!